Endocarditis (Streptococcus mitis)

Overview


Plain-Language Overview

Endocarditis (Streptococcus mitis) is an infection of the inner lining of the heart, particularly affecting the heart valves. This condition involves the growth of bacterial colonies on the heart valves, which can interfere with normal heart function. The infection primarily affects the cardiovascular system and can lead to serious complications such as heart valve damage and heart failure. Symptoms often include fever, fatigue, and heart murmurs. If untreated, it can cause blood clots or spread infection to other parts of the body, making it a potentially life-threatening condition.

Clinical Definition

Endocarditis (Streptococcus mitis) is a form of infective endocarditis characterized by the colonization of heart valves by the viridans group streptococci, particularly Streptococcus mitis. The core pathology involves the formation of vegetations composed of bacteria, fibrin, and inflammatory cells on the endocardial surface, most commonly affecting previously damaged or prosthetic valves. This condition arises due to bacteremia, often following dental procedures or poor oral hygiene, allowing S. mitis to adhere to the endocardium. It is clinically significant because it can cause valvular insufficiency, systemic emboli, and immune complex-mediated phenomena. The disease course can be subacute, with nonspecific symptoms such as fever, malaise, and heart murmur development. Early recognition and treatment are critical to prevent severe complications including heart failure and systemic embolization.

Inciting Event

  • Transient bacteremia following dental manipulation or oral trauma is the typical trigger.

  • Invasive procedures involving mucosal surfaces can introduce S. mitis into the bloodstream.

  • Spontaneous bacteremia in patients with poor oral hygiene may initiate infection.

Latency Period

  • Symptoms typically develop over days to weeks after bacteremia onset.

  • Subacute presentation with gradual symptom progression is common in S. mitis endocarditis.

Diagnostic Delay

  • Nonspecific symptoms such as fever and malaise often lead to delayed suspicion.

  • Negative initial blood cultures may occur if antibiotics were given prior to sampling.

  • Overlap with other febrile illnesses can mislead clinicians away from endocarditis.

Clinical Presentation


Signs & Symptoms

  • Fever and chills as the most common presenting symptoms

  • Fatigue and malaise due to systemic infection

  • New or worsening heart murmur indicating valvular involvement

  • Night sweats and weight loss in subacute presentations

  • Signs of embolic phenomena such as stroke, splenic infarcts, or petechiae

History of Present Illness

  • Low-grade fever and fatigue develop insidiously over weeks.

  • New or changing heart murmur is a key clinical clue.

  • Symptoms of embolic phenomena such as stroke or splinter hemorrhages may appear.

  • Night sweats and weight loss are common systemic signs.

Past Medical History

  • History of valvular heart disease or prior endocarditis increases risk.

  • Recent dental procedures or poor oral hygiene are important antecedents.

  • Presence of prosthetic heart valves or intracardiac devices predisposes to infection.

Family History

  • []

Physical Exam Findings

  • New or changing heart murmur, often a regurgitant murmur due to valvular damage

  • Splinter hemorrhages under the fingernails or toenails indicating microvascular emboli

  • Janeway lesions, painless erythematous macules on palms and soles from septic emboli

  • Osler nodes, tender subcutaneous nodules on fingers or toes caused by immune complex deposition

  • Roth spots, retinal hemorrhages with pale centers seen on fundoscopic exam

Diagnostic Workup


Diagnostic Criteria

Diagnosis of endocarditis relies on the Duke criteria, which include major and minor clinical, microbiological, and echocardiographic findings. Key diagnostic features include positive blood cultures for Streptococcus mitis and evidence of endocardial involvement on echocardiography (vegetations, abscess, or new valvular regurgitation). Minor criteria include predisposing heart conditions, fever, vascular phenomena, and immunologic signs. Confirmatory diagnosis requires either two major criteria, one major and three minor criteria, or five minor criteria. Blood cultures must be obtained before starting antibiotics to maximize diagnostic yield.

Pathophysiology


Key Mechanisms

  • Bacteremia allows Streptococcus mitis to adhere to damaged or abnormal heart valves via platelet-fibrin thrombi.

  • Vegetation formation on valves leads to local tissue destruction and embolic phenomena.

  • Immune complex deposition causes systemic manifestations such as glomerulonephritis and vasculitis.

  • Valve destruction results in valvular insufficiency and heart failure.

InvolvementDetails
Organs

Heart is the main organ involved, with infection primarily affecting the cardiac valves leading to valvular dysfunction.

Kidneys may be affected by immune complex deposition causing glomerulonephritis as a complication of endocarditis.

Tissues

Endocardium is the primary tissue affected, where bacterial colonization and vegetation formation occur on heart valves.

Valvular tissue undergoes destruction and fibrosis due to bacterial invasion and immune response.

Cells

Neutrophils play a key role in phagocytosing bacteria and mediating acute inflammation in infective endocarditis.

Macrophages contribute to chronic inflammation and tissue remodeling around infected heart valves.

Platelets aggregate on damaged endocardium, facilitating vegetation formation with bacteria and fibrin.

Chemical Mediators

Interleukin-1 (IL-1) promotes inflammation and fever during the systemic response to infection.

Tumor necrosis factor-alpha (TNF-α) mediates endothelial activation and contributes to tissue damage in infected valves.

C-reactive protein (CRP) is an acute phase reactant elevated in response to bacterial infection and inflammation.

Treatments


Pharmacological Treatments

  • Penicillin G

    • Mechanism:
      • Binds to penicillin-binding proteins to inhibit bacterial cell wall synthesis, leading to bacterial lysis.

    • Side effects:
      • Allergic reactions

      • Nephrotoxicity

      • Gastrointestinal upset

    • Clinical role:
      • First-line

  • Gentamicin

    • Mechanism:
      • Binds to the 30S ribosomal subunit, causing misreading of mRNA and inhibiting bacterial protein synthesis.

    • Side effects:
      • Nephrotoxicity

      • Ototoxicity

      • Neuromuscular blockade

    • Clinical role:
      • Adjunctive

  • Vancomycin

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors.

    • Side effects:
      • Nephrotoxicity

      • Red man syndrome

      • Ototoxicity

    • Clinical role:
      • Second-line

Non-pharmacological Treatments

  • Surgical valve repair or replacement is indicated in cases of heart failure, uncontrolled infection, or large vegetations causing embolic risk.

  • Supportive care includes management of heart failure symptoms and monitoring for embolic complications.

Prevention


Pharmacological Prevention

  • Prophylactic antibiotics (e.g., amoxicillin) before dental procedures in high-risk patients

  • Early and appropriate antibiotic therapy targeting Streptococcus mitis to prevent complications

  • Use of bactericidal antibiotics such as penicillin or ceftriaxone for treatment

  • Monitoring and adjusting antibiotic duration based on clinical response and blood culture clearance

  • Avoidance of unnecessary invasive procedures without prophylaxis in at-risk individuals

Non-pharmacological Prevention

  • Good oral hygiene to reduce bacterial load from Streptococcus mitis in the mouth

  • Regular dental care and prompt treatment of dental infections

  • Screening and management of predisposing valvular heart disease

  • Avoidance of intravenous drug use to reduce bacteremia risk

  • Education on recognizing early symptoms to seek timely medical care

Outcome & Complications


Complications

  • Heart failure due to valvular destruction and regurgitation

  • Systemic embolization causing stroke, splenic infarcts, or renal infarcts

  • Perivalvular abscess formation leading to conduction abnormalities

  • Septic emboli causing metastatic infections such as brain abscess

  • Glomerulonephritis from immune complex deposition

Short-term Sequelae Long-term Sequelae
  • Persistent bacteremia despite antibiotics

  • Acute valvular insufficiency causing hemodynamic instability

  • Septic emboli leading to infarcts or abscesses in distant organs

  • Conduction abnormalities from perivalvular extension

  • Sepsis and systemic inflammatory response syndrome

  • Chronic valvular heart disease requiring surgical repair or replacement

  • Recurrent endocarditis especially if predisposing factors persist

  • Heart failure from progressive valvular dysfunction

  • Permanent neurological deficits from embolic strokes

  • Chronic kidney disease secondary to glomerulonephritis

Differential Diagnoses


Endocarditis (Streptococcus mitis) versus Infective Endocarditis due to Staphylococcus aureus

Endocarditis (Streptococcus mitis)

Infective Endocarditis due to Staphylococcus aureus

Gram-positive cocci in chains, part of viridans group streptococci causing subacute infection

Gram-positive cocci in clusters, often causing acute, aggressive infection

Usually presents with indolent symptoms over weeks with low-grade fever

Typically presents with rapid onset of high fever and severe systemic symptoms

Commonly follows dental procedures or poor dental hygiene

Often associated with intravenous drug use or healthcare-associated infections

Responds well to penicillin or ceftriaxone targeting viridans streptococci

Requires anti-staphylococcal antibiotics such as nafcillin or vancomycin

Endocarditis (Streptococcus mitis) versus Nonbacterial Thrombotic Endocarditis (NBTE)

Endocarditis (Streptococcus mitis)

Nonbacterial Thrombotic Endocarditis (NBTE)

Vegetations containing bacteria and inflammatory cells

Sterile vegetations composed of fibrin and platelets without microorganisms

Presents with infectious symptoms such as fever and positive blood cultures

Often associated with malignancy or hypercoagulable states and lacks infection signs

Positive blood cultures for Streptococcus mitis

Negative blood cultures despite presence of vegetations on echocardiogram

Endocarditis (Streptococcus mitis) versus Rheumatic Heart Disease

Endocarditis (Streptococcus mitis)

Rheumatic Heart Disease

No preceding pharyngitis; infection originates from oral flora

History of untreated group A streptococcal pharyngitis weeks prior

Acute bacterial vegetations without Aschoff bodies

Chronic valvular scarring with Aschoff bodies and verrucae on valve leaflets

Acute or subacute infection with active vegetations

Chronic progressive valvular dysfunction often years after initial illness

Endocarditis (Streptococcus mitis) versus Culture-Negative Endocarditis

Endocarditis (Streptococcus mitis)

Culture-Negative Endocarditis

Positive blood cultures growing Streptococcus mitis

Negative blood cultures due to fastidious organisms or prior antibiotics

Caused by viridans group streptococci, specifically Streptococcus mitis

Often caused by Coxiella burnetii, Bartonella species, or HACEK organisms

Responds to targeted beta-lactam antibiotics based on culture sensitivity

Requires prolonged empiric therapy covering atypical organisms

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.